Richard Adcock
CIK 1830328 · CEO & President · last filed 2026-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.99M
Companies
2
Total Filings
17
Lifetime Open-Market Net
$17.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | CEO & President | 562,274 | $7.10 | $3.99M | $17.0K | 16 | 2026-02-24 |
| ImmunityBio, Inc. (NK) Delisted | Chief Executive Officer | 150,000 | — | — | $0 | 1 | 2021-02-09 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | IBRX | Mixed | +4,347 | -$21.7K | EDGAR |
| 2022-03-25 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2022-02-08 | IBRX | Mixed | +53,918 | -$158.5K | EDGAR |
| 2021-10-08 | IBRX | Buy (P) | +1,930 | $17.0K | EDGAR |
| 2021-09-13 | IBRX | Mixed | +4,347 | -$42.5K | EDGAR |
| 2021-04-14 | IBRX | Other (J) | — | $0 | EDGAR |
| 2021-02-09 | ImmunityBio, Inc. (NK) Delisted | Mixed | +81,829 | -$1.62M | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.